Total acid phosphatase (TAP), prostatic acid phosphatase (PAP) and non-prostatic acid phosphatase (NPAP) serum concentrations were determined using a spectrophotometric technique in 52 healthy dogs, 15 male dogs suffering from non-prostatic diseases and in 19 dogs suffering from prostatic diseases (12 dogs with benign prostatic hypertrophy and seven dogs with prostatic adenocarcinoma). TAP, PAP and NPAP serum concentrations did not differ between normal male and normal female dogs. Dogs with prostatic adenocarcinoma had significantly higher TAP, PAP and NPAP serum concentrations than dogs with benign prostatic hypertrophy, normal dogs and dogs with non-prostatic disease. The authors conclude that low serum concentrations of TAP and PAP do not rule out prostatic adenocarcinoma in the dog, but elevated concentrations can be useful criteria for the diagnosis of canine prostatic cancer.
|Autori:||CORAZZA M.; GUIDI G.; ROMAGNOLI S.; TOGNETTI R.; BUONACCORSI A|
|Titolo:||SERUM TOTAL PROSTATIC AND NON-PROSTATIC ACID PHOSPHATASE IN HEALTHY DOGS AND IN DOGS WITH PROSTATIC DISEASES|
|Anno del prodotto:||1994|
|Digital Object Identifier (DOI):||10.1111/j.1748-5827.1994.tb03292.x|
|Appare nelle tipologie:||1.1 Articolo in rivista|